UBS Group
PLXP

UBS Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

UBS Group’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-51,213
Closed -$6.66K – 10392
2023
Q1 		$6.66K Sell
51,213
-32,510
-39% -$6.61K ﹤0.01% 7902
2022
Q4 		$13.4K Buy
83,723
+27,752
+50% +$11.6K ﹤0.01% 8170
2022
Q3 		$36K Buy
55,971
+4,839
+9% +$7.13K ﹤0.01% 6676
2022
Q2 		$124K Hold
51,132
– – ﹤0.01% 5262
2022
Q1 		$207K Sell
51,132
-7,291
-12% -$40K ﹤0.01% 5325
2021
Q4 		$468K Buy
58,423
+18,425
+46% +$216K ﹤0.01% 5034
2021
Q3 		$772K Buy
39,998
+22,986
+135% +$402K ﹤0.01% 4399
2021
Q2 		$235K Buy
17,012
+3,161
+23% +$37.4K ﹤0.01% 5237
2021
Q1 		$125K Buy
13,851
+11,531
+497% +$84.3K ﹤0.01% 5791
2020
Q4 		$13K Sell
2,320
-1,473
-39% -$6.51K ﹤0.01% 7306
2020
Q3 		$12K Buy
3,793
+2,740
+260% +$9.18K ﹤0.01% 6724
2020
Q2 		$3K Sell
1,053
-781
-43% -$2.36K ﹤0.01% 7576
2020
Q1 		$4K Buy
1,834
+781
+74% +$3.58K ﹤0.01% 7433
2019
Q4 		$5K Hold
1,053
– – ﹤0.01% 7611
2019
Q3 		$5K Sell
1,053
-2,491
-70% -$14.5K ﹤0.01% 7507
2019
Q2 		$26K Buy
3,544
+627
+21% +$3.4K ﹤0.01% 6449
2019
Q1 		$16K Sell
2,917
-9,595
-77% -$46.9K ﹤0.01% 6515
2018
Q4 		$19K Sell
12,512
-769
-6% -$2.74K ﹤0.01% 6847
2018
Q3 		$54K Buy
13,281
+1,441
+12% +$5.42K ﹤0.01% 6108
2018
Q2 		$46K Sell
11,840
-2,157
-15% -$8.81K ﹤0.01% 6044
2018
Q1 		$47K Buy
13,997
+1,086
+8% +$6.88K ﹤0.01% 5762
2017
Q4 		$89K Buy
12,911
+1,071
+9% +$7.43K ﹤0.01% 5445
2017
Q3 		$76K Buy
11,840
+11,787
+22,240% +$75.6K ﹤0.01% 5510
2017
Q2 		$0 Sell
53
-1
-2% -$7 ﹤0.01% 8094
2017
Q1 		$1K Sell
54
-9
-14% -$98 ﹤0.01% 7491
2016
Q4 		$1K Sell
63
-14
-18% -$514 ﹤0.01% 7666
2016
Q3 		$9K Buy
77
+14
+22% +$1.36K ﹤0.01% 6862
2016
Q2 		$5K Hold
63
– – ﹤0.01% 7150
2016
Q1 		$5K Sell
63
-214
-77% -$13.6K ﹤0.01% 7024
2015
Q4 		$25K Buy
277
+14
+5% +$1.34K ﹤0.01% 6527
2015
Q3 		$29K Buy
263
+91
+53% +$10.5K ﹤0.01% 6336
2015
Q2 		$17K Sell
172
-21
-11% -$2.17K ﹤0.01% 7038
2015
Q1 		$21K Buy
193
+130
+206% +$13.3K ﹤0.01% 6954
2014
Q4 		$6K Buy
+63
New +$5.37K ﹤0.01% 8872

Other funds holding PLXP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

UBS Group's PLXP Position: Q2 2023 in Review

UBS Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 51,213 shares — an estimated $6.66K sold.

UBS Group first reported a position in PLXP in Q4 2014 and held it in 34 quarters. The position peaked at $772K in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • UBS Group reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 51,213 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $6.66K.
  • UBS Group first reported a position in PLx Pharma Inc. Common Stock in Q4 2014 and held it in 34 quarters.
  • UBS Group's PLx Pharma Inc. Common Stock position peaked at $772K in Q3 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.